PROCEPT INC
3, 1998-09-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: KEMPER TAX EXE INS INCOME TR SER A 81 & MULTI STATE SER 49, 485BPOS, 1998-09-10
Next: PROCEPT INC, SC 13D/A, 1998-09-10





| FORM 3 |

                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

        Filed pursuant to Section 16(a) of the Securities Exchange Act of
        1934, Section 17(a) of the Public Utility Holding Company Act of
           1935 or Section 30(f) of the Investment Company Act of 1940

- --------------------------------------------------------------------------------
1. Name and Address of Reporting Person
   Lindsay A. Rosenwald, M.D.
   787 Seventh Avenue, 48th Floor
   New York, NY 10019

- --------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)
   06/30/97

- --------------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person (Voluntary)

- --------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
   Procept Inc -- PRCT

- --------------------------------------------------------------------------------
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director  (X) 10% Owner  ( ) Officer (give title below) ( ) Other
   (specify below)
   
- --------------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
   
- --------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person

<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------------|
 TABLE I -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED                                                                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
1. Title of Security                       |2. Amount of          |3. Ownership    |4. Nature of Indirect                          |
                                           |   Securities         |   Form:        |   Beneficial Ownership                        |
                                           |   Beneficially       |   Direct(D) or |                                               |
                                           |   Owned              |   Indirect(I)  |                                               |
- -----------------------------------------------------------------------------------------------------------------------------------|
<S>                                        <C>                    <C>              <C>
Common Stock, $0.01 par value per share (1)|5,973,334 (2)         |I               |(3)                                            |
- -----------------------------------------------------------------------------------------------------------------------------------|

Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly. (Over)

                     (Print or Type Responses) SEC1473(3/91)

* If the Form is filed by more than one Reporting Person, see Instruction
  5(b)(v).

                                   Page 1 of 2


<PAGE>
<CAPTION>

FORM 3 (CONTINUED) TABLE II--DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
- -----------------------------------------------------------------------------------------------------------------------------------|
1.Title of Derivative   |2.Date Exer-       |3.Title and Amount     |         |4. Conver-|5. Owner-    |6. Nature of Indirect      |
  Security              |  cisable and      |  of Underlying        |         |sion or   |ship         |   Beneficial Ownership    |
                        |  Expiration       |  Securities           |         |exercise  |Form of      |                           |
                        |  Date(Month/      |-----------------------|---------|price of  |Deriv-       |                           |
                        |  Day/Year)        |                       |Amount   |deri-     |ative        |                           |
                        | Date    | Expira- |                       |or       |vative    |Security:    |                           |
                        | Exer-   | tion    |         Title         |Number of|Security  |Direct(D) or |                           |
                        | cisable | Date    |                       |Shares   |          |Indirect(I)  |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
<S>                     <C>       <C>       <C>                     <C>       <C>        <C>           <C>
Class A Warrants        |06/30/97 |06/30/02 |Common Stock           |2,742,696|$0.01(2)  |I            |(3)                        |
                        |         |         |                       |(2)      |          |             |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class B Warrants        |06/30/97 |06/30/02 |Common Stock           |7,602,132|$0.5859(2)|I            |(3)                        |
                        |         |         |                       |(2)      |          |             |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
12% Senior Convertible  |06/30/97 |N/A      |Common Stock(1)        |426,666  |$0.46875(2|I            |(3)                        |
Notes                   |         |         |                       |(2)      |)         |             |                           |
===================================================================================================================================|
</TABLE>

Explanation of Responses:

(1) Upon the approval by the  stockholders of the Issuer of a pending  amendment
    to the Issuer's  Certificate  of  Incorporation  authorizing  "blank  check"
    preferred  stock,  the Aries  Funds (as  defined  below) may (i) require the
    Issuer to designate a Series A Convertible  Preferred Stock,  (ii) put their
    Common  Stock to the  Issuer for Series A  Convertible  Preferred  Stock and
    (iii) elect to convert  their  Senior  Convertible  Notes into such Series A
    Convertible Preferred Stock instead of into Common Stock.

(2) Upon the  earliest of (i) the approval by the holders of Common Stock of the
    Issuer of the transactions contemplated by the Securities Purchase Agreement
    between  the  Issuer  and the  Aries  Funds  (the  "Transactions")  that are
    required by Rule 4460(i) of the National  Association of Securities Dealers'
    Marketplace  Rules,  (ii) any event which renders such stockholder  approval
    unnecessary or which renders such Rule  inapplicable and (iii) September 30,
    1997,  the Aries Funds shall be entitled  to a  distribution  of  additional
    shares of Common Stock, and the respective exercise and conversion prices of
    the Class A Warrants, class B Warrants and Senior Convertible Notes shall be
    adjusted to equal the lesser of $.29 and 50% of various market-based prices.

(3) The  Reporting  Person is the President  and sole  shareholder  of Paramount
    Capital  Asset  Management,  Inc.  ("Paramount").  Paramount  is the General
    Partner of the Aries Domestic Fund, L.P. (the "Partnership") and also serves
    as the  Investment  Manager  to The Aries  Trust (the  "Trust"  and with the
    Partnership,  the "Aries Funds"), a Cayman Islands trust.  While, as of June
    30 1997, the Reporting Person owns directly no securities of the Issuer, the
    Aries Funds each owns  securities  of the Issuer.  Dr.  Rosenwald  disclaims
    beneficial  ownership of the securities  held by the Aries Funds,  except to
    the extent of his pecuniary interest therein, if any.

**  Intentional  misstatements or omissions of facts constitute Federal Criminal
    Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).


                                                                         9/10/98
___________________________________                                      -------
Lindsay A. Rosenwald, M.D. 
   ** Signature of Reporting Person


Note:     File three copies of this Form, one of which must be manually  signed.
          If space provided is insufficient, See Instruction 6 for procedure

Potential persons who are to respond to the collection of information  contained
in this form are not  required to respond  unless the form  displays a currently
valid OMB Number.

                                   Page 2 of 2




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission